Supply of Oral Transmucosal Fentanyl Citrate OTFC
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 +1 more |
| Procedure | limited |
| OCID | ocds-h6vhtk-02e04d |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Mawdsley – Brooks & Co LTD | · | · | active |
description
The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of the Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), intends to place a contract with Mawdsley-Brooks & Co Ltd for the supply of Single Oral Transmucosal Fentanyl Citrate (OTFC) lozenges for a period of 5 years (1 + 4 Option Years) with an estimated maximum value of £1.944M. This is necessary to ensure maintenance of the capability within an acceptable stockholding level.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 13 Sept 2021 | Voluntary ex-ante transparency (F15) | Earlier regulations | 022750-2021 |
more from Ministry of Defence
- TTHC/0017 CONTRACTS FINDER AWARDED CONTRACT · £135,254,246 · 30 Jul 2026
- TTHC/0017 Torpedoes Repair and Maintenance (TRAM) · 29 Jul 2026
- 713107450 In Service Support of Type 45, Integrated Navigation and Bridge System Award notice · £9,888,089 · 28 Jul 2026
- SUPPLY CHAIN NOTICE - Calibration Services For Tooling Supporting Boeing, Vertical Lift Helicopters. · £12,000 · 28 Jul 2026
- SUPPLY CHAIN NOTICE - WC1996767 - (MT0019, MT0106, MT0265, MT0494) - Remedial works required to M&T Structures from the PAs, Akrotiri & Dhekelia, CYPRUS · 28 Jul 2026
- 715878489 - MCF 4 Order Form · £1,082,000 · 28 Jul 2026
- Provision of Foreign Currency SUpply to 2028 · £800,000,000 · 28 Jul 2026
- 704461451-MSS/141-SPA707 - CAN · £1 · 28 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.